Pharmacodynamics Flashcards

1
Q

Define ligand

A

Molecule that binds to a receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Define agonist

Define antagonist

A

Ligand that activates a receptor and produces a measurable biological response

Ligand that inactivates or prevents an agonist from activating a receptor, producing no measurable biological response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Define partial agonist and state it’s values for Emax, intrinsic efficacy, affinity, and potency

A
Ligand that activates a receptor and produces a measurable biological response but one that is lower than the response of a full agonist
Lower Emax
Lower intrinsic efficacy
Same potency
Same affinity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q
Define:
Affinity
Intrinsic efficacy
Ligand efficacy
Agonist potency
A

Affinity: Ability of a ligand to bind to a receptor
Intrinsic efficacy: Ability of an agonist to generate the active form of a receptor
Ligand efficacy: Ability of the agonist-receptor complex to produce a measurable biological response after activation of the receptor
Potency: Ability of an agonist to produce its maximum biological repsonse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Define:
Kd
EC50

A

Kd: conc. of ligand that binds to half the available receptors
EC50: conc. of agonist that produces half of its max response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is potency dependent upon?

A

Affinity
Efficacy
Cell specific components

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is Kd also known as?

A

Dissociation constant: strength of the interaction between ligand and receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How does the Kd affect the selectivity of a ligand?

A

Ligands have different affinity’s for different receptors

Greater difference in Kd, more drug is available to administer without side-effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are spare receptors?

A

Tissues contain an excess number of receptors than what is needed for the Emax
Therefore, tissues have an increased sensitivity to ligands (signal amplification or multiple signals)
Allows an equivalent response following the loss of receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe how changes in the number of receptors will affect the response of a cell

A

Change in the number of receptors will cause a reciprocal change in Emax, EC50, Bmax, Kd

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Explain the terms down-regulation and up-regulation and their causes

A

Down-regulation: receptor numbers decrease due to high activity
Up-regulation: receptor numbers increase due to low activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How do partial agonists allow a controlled response and what is an example?

A

Can act as an antagonist in the presence of a full agonist
Buprenorphine is a partial agonist with a higher affinity than heroin for (micro-)opioid receptors causing withdrawal symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe what functional antagonism is

A

An antagonist that uses a different pathway (to the agonist) to oppose the effects of the agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the different types of conventional antagonism?

A

Competitive (reversible and irreversible)

Non-competitive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe the action of reversible competitive antagonists

A

Non-covalent binding to the receptor
Dynamic equilibrium of antagonist and agonist (inhibition only when [Antagonist] > [Agonist])
Increases Kd

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe the action of irreversible competitive antagonists

A

Covalent binding to the receptor
Slow dissociation (inhibition when antagonist is present)
Increases Kd and EC50

17
Q

Describe the action of non-competitive antagonists

A

Binding at allosteric site
Antagonists allosterically modulate Active site of receptor
Reduce orthosteric (natural site) ligands affinity and intrinsic efficacy
Increases Kd and EC50